BAKER BROS. ADVISORS LP
SEC insider (Form 3/4/5 filer). CIK 0001263508. Director & 10% Owner at INCYTE CORP (INCY) and 9 other issuers. 216 reported Form 4/5 transactions since Sep 2024; latest on Sep 30, 2026. Located in NEW YORK, NY.
Companies BAKER BROS. ADVISORS LP has filed insider reports for
- INCYTE CORP (INCY): Director, 10% Owner
- Replimune Group, Inc. (REPL): Director, 10% Owner
- Celcuity Inc. (CELC)
- Kodiak Sciences Inc. (KOD): Director, 10% Owner
- vTv Therapeutics Inc. (VTVT): Director
- Kymera Therapeutics, Inc. (KYMR): Director, 10% Owner
- MADRIGAL PHARMACEUTICALS, INC. (MDGL): Director
- BeOne Medicines Ltd. (ONC): Director
- Prelude Therapeutics Inc (PRLD): Director, 10% Owner
- Denali Therapeutics Inc. (DNLI): Director
BAKER BROS. ADVISORS LP
CIK: 0001263508
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (20)
INCYTE CORP
Replimune Group, Inc.
Celcuity Inc.
Kodiak Sciences Inc.
vTv Therapeutics Inc.
Kymera Therapeutics, Inc.
MADRIGAL PHARMACEUTICALS, INC.
BeOne Medicines Ltd.
Prelude Therapeutics Inc
Denali Therapeutics Inc.
ACADIA PHARMACEUTICALS INC
Kiniksa Pharmaceuticals International, plc
TScan Therapeutics, Inc.
DBV Technologies S.A.
BICYCLE THERAPEUTICS PLC
Entrada Therapeutics, Inc.
KALA BIO, Inc.
IGM Biosciences, Inc.
Immunocore Holdings plc
SERA PROGNOSTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (216 total)
- Sep 30, 2026INCY
INCYTE CORP
AwardIndirect322 shares- - Sep 30, 2026INCY
INCYTE CORP
AwardIndirect322 shares- - Aug 11, 2026REPL
Replimune Group, Inc.
PurchaseIndirect2026 $0.0001 Prefunded Warrants
2.6M shares at avg. $12.06- - Aug 11, 2026REPL
Replimune Group, Inc.
PurchaseIndirect2026 $0.0001 Prefunded Warrants
126.4K shares at avg. $12.06- - Jul 14, 2026CELC
Celcuity Inc.
SaleIndirect261.4K shares at avg. $102.50$26.8M - Jul 14, 2026CELC
Celcuity Inc.
SaleIndirect2.8M shares at avg. $102.50$291.0M - Jun 30, 2026KOD
Kodiak Sciences Inc.
AwardIndirectNon-Qualified Stock Options (right to buy)
17.7K shares- - Jun 30, 2026KOD
Kodiak Sciences Inc.
AwardIndirectNon-Qualified Stock Options (right to buy)
17.7K shares- - Jun 30, 2026INCY
INCYTE CORP
AwardIndirect400 shares- - Jun 30, 2026INCY
INCYTE CORP
AwardIndirect400 shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Sep 30, 2026 | INCY INCYTE CORP | Award | 322 | - | $0 | Indirect |
| Sep 30, 2026 | INCY INCYTE CORP | Award | 322 | - | $0 | Indirect |
| Aug 11, 2026 | REPL Replimune Group, Inc. | Purchase 2026 $0.0001 Prefunded Warrants | 2,609,946 | $12.06 | - | Indirect |
| Aug 11, 2026 | REPL Replimune Group, Inc. | Purchase 2026 $0.0001 Prefunded Warrants | 126,394 | $12.06 | - | Indirect |
| Jul 14, 2026 | CELC Celcuity Inc. | Sale | 261,368 | $102.50 | $26,790,220 | Indirect |
| Jul 14, 2026 | CELC Celcuity Inc. | Sale | 2,838,632 | $102.50 | $290,959,780 | Indirect |
| Jun 30, 2026 | KOD Kodiak Sciences Inc. | Award Non-Qualified Stock Options (right to buy) | 17,731 | - | - | Indirect |
| Jun 30, 2026 | KOD Kodiak Sciences Inc. | Award Non-Qualified Stock Options (right to buy) | 17,731 | - | - | Indirect |
| Jun 30, 2026 | INCY INCYTE CORP | Award | 400 | - | $0 | Indirect |
| Jun 30, 2026 | INCY INCYTE CORP | Award | 400 | - | $0 | Indirect |
1-10 of 216 transactions